Allterum Therapeutics
PrivateLast Round
Grant
Sep 9, 2025
Total Funding Raised
$22.42M
Momentum Score
25 /100
Company Overview
Allterum Therapeutics is a clinical-stage biotechnology company developing a monoclonal antibody targeting the interleukin-7 receptor for the treatment of cancers such as Acute Lymphoblastic Leukemia (ALL).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allterum Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Allterum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 9, 2025 | ||||
| Grant | Jun 13, 2025 | ||||
| Grant | Apr 8, 2024 | ||||
| Grant | Jul 19, 2023 | ||||
| Seed | Dec 17, 2020 | ||||
Grant | Apr 21, 2020 |
Allterum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 109% MoM.
- Nov 11, 2025
Granted for Acute Lymphoblastic Leukemia treatment 4A10.
Allterum Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allterum Therapeutics's valuation, stock price, and market status.
